BioSpace News Archive

Deals

Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on November 1, 2018

Sage Therapeutics today announced that, on November 1, 2018, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 15,400 shares of its common stock to 12 new employees under Sage’s 2016 Inducement Equity Plan.

November 5, 2018
·
2 min read
Pharm Country

Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease

Jardiance (empagliflozin) was associated with a 44 percent reduction in relative risk of hospitalization for heart failure (HHF) compared with commonly used dipeptidyl peptidase-4 inhibitors

November 5, 2018
·
16 min read
Trulicity® (dulaglutide) demonstrates superiority in reduction of cardiovascular events for broad range of people with type 2 diabetes

Only 31 percent of REWIND trial participants had established CV disease

November 5, 2018
·
11 min read
Business

Check-Cap Reports Third Quarter 2018 Financial Results

Announced Interim Results from Post-CE Approval Study of C-Scan®

November 5, 2018
·
11 min read
Business

Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer

Plans to Initiate MARIO-275, a Randomized, Global Phase 2 Study in 1H'19

November 5, 2018
·
27 min read
Business

Avanos Medical, Inc. to Present at Stifel 2018 Healthcare Conference

Avanos Medical, Inc. today announced that Joe Woody, chief executive officer, will present at the Stifel 2018 Healthcare Conference at The Lotte New York Palace Hotel in New York City on Tuesday, Nov. 13 at approximately 11 a.m., ET.

November 5, 2018
·
1 min read
Business

Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results

Conference Call and Webcast Today at 8:30 a.m. EST / 5:30 a.m. PST

November 5, 2018
·
11 min read
Beleave Announces Seven-for-One Share Split

Each shareholder of record of the Company as of the close of business on the Record Date will receive six additional shares for each share held on such date.

November 5, 2018
·
3 min read
Biotech Beach

Ablexis Announces Antibody Discovered Using AlivaMab Mouse Platform Enters Clinical Development

Further validates efficiency of AlivaMab Mouse for antibody drug discovery and development

November 5, 2018
·
2 min read
Job Trends

Recursion Pharmaceuticals Named One of Utah’s 2018 Top Workplaces by The Salt Lake Tribune

Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, has been awarded a 2018 Top Workplaces award by The Salt Lake Tribune.

November 5, 2018
·
3 min read